Format

Send to

Choose Destination
Science. 2017 Sep 1;357(6354):876-877. doi: 10.1126/science.aao1056.

Influence, integrity, and the FDA: An ethical framework.

Author information

1
Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA.
2
Center for Bioethics, Harvard Medical School, Boston, MA 02115, USA.
3
Petrie-Flom Center, Harvard Law School, Cambridge, MA 02138, USA.
4
Warren Alpert Medical School, Brown University, Providence, RI 02903, USA.
5
Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02120, USA. akesselheim@bwh.harvard.edu.
PMID:
28860375
DOI:
10.1126/science.aao1056
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center